DarioHealth Reports Strong Second Quarter 2021 Results and Operational Highlights

Go back to DarioHealth Reports Strong Second Quarter 2021 Results and Operational Highlights

DarioHealth (DRIO) Misses Q2 EPS by 14c

August 16, 2021 6:42 AM EDT

DarioHealth (NASDAQ: DRIO) reported Q2 EPS of ($0.99), $0.14 worse than the analyst estimate of ($0.85). Revenue for the quarter came in at $5.3 million versus the consensus estimate of $5.11 million.

For earnings history and earnings-related data on DarioHealth (DRIO) click here.

... More